top of page
Medical treatment
Wegovy
Semaglutide
Weekly injection. Average weight loss of 10 to 15% of body weight, with significant cardiovascular risk reduction.
Mounjaro
Tirzepatide
Dual GLP-1 and GIP agonist. Average weight loss of up to 20% of body weight in 72 weeks.
Medication is never prescribed in isolation. Every patient is managed within Dr Manning's 360 framework.
An important consideration
Physician led, data driven weight management
Significant weight loss can affect facial appearance, hollowing of the cheeks, loss of jawline definition, increased skin laxity. Dr Manning designs weight loss programmes that anticipate and address this from the beginning, not as an afterthought.
Considered questions
Before you
book.
bottom of page
